Oral contraception is used by one hundred million women worldwide for contraceptive purposes. Side effects are widely publicized. However non-contraceptive benefits are unknown women and the medical profession and deserve to be explored.
A review of the literature allowed us to gather a majority of non-contraceptive benefits of oral contraception.

The prevalence of pregnancy after breast cancer is increasing, since breast cancer occurs in 10-15% of cases in patients under 40 years. This literature review aims to make an update for defining a multidisciplinary management of a patient with a desire for pregnancy after breast cancer.

Interstitial pregnancy is a rare form of ectopic pregnancy, but it is associated with the highest risk of morbidity and mortality and needs early diagnosis. Interstitial, angular and cornual pregnancies are mistakenly and frequently confused and need a strict distinction. Interstitial pregnancy refers to an ectopic pregnancy that is implanted in the interstitial portion of the fallopian tube. Its correct diagnosis can be quite difficult; it relies heavily on quantitative beta-hCG assays and ultrasound and potentially on laparoscopic evaluation. The diagnosis by transvaginale ultrasonography is based on multiple criteria. Several effective treatment options for treatment of interstitial pregnancy have been described but the most appropriate technique remains controversial. Managing an interstitial pregnancy is dependent upon whether the ectopic pregnancy has ruptured, the stability of the patient, the gestational age at diagnosis and the patient's desire for future fertility. The greatest risk to patients after successful treatment remains recurrence of interstitial pregnancy and the uterine rupture during subsequent pregnancy this is why a transvaginale ultrasonography should be performed 5-6 weeks after the last menstrual period and a cesarean delivery should be planned at term or performed, if tocolysis fails in cases of preterm labor. To illustrate the particularities of this form of ectopic pregnancy we report two cases with a brief up date.

Introduction: Cystic lymphangioma of the ovary is a rare benign vascular tumor. Its histogenesis is still hypothetical and its preoperative diagnosis difficult to establish. We report a case of cystic lymphangioma of the ovary that was a problem with differential malignant ovarian tumor diagnosis, with a recent review of the literature.
Observation: Patient 35 years primigravida primipara without significant pelvic pain consults history dating back more than three months without increased abdominal volume or urinary or digestive signs associated. A pelvic ultrasound done complemented by magnetic resonance imaging have objectified aspect for a right ovarian cyst formation by 8 cm to confront the histological data. The patient underwent a right oophorectomy returned for mature cystic teratoma of a cystic hygroma associated. The postoperative course was uneventful and no recurrence was noted.
Results: Cystic lymphangioma of the ovary is rare benign tumor formation. There are no specific symptoms. Radiology despite progress remains inconclusive in the diagnosis of this tumor type. Histological study is the only way to confirm the diagnosis. The outcome was favorable, no cases of malignant transformation have been reported.
Conclusion: Cystic lymphangioma of the ovary is a rare benign tumor of the malformation. The diagnosis rarely made preoperatively should be considered in any cystic ovarian mass. Only complete surgical resection of the tumor is associated with prolonged survival and a favorable prognosis.